Insider Trading & Ownership of Pontifax Management 4 G.P. (2015) Ltd.

Location
Herzliya Pituach, Israel
Summary
The estimated value of insider holdings of Pontifax Management 4 G.P. (2015) Ltd. is at least $610,056 dollars as of 17 Oct 2025. Pontifax Management 4 G.P. (2015) Ltd. is the 10%+ Owner of Eloxx Pharmaceuticals, Inc. and owns shares of Eloxx Pharmaceuticals, Inc. stock worth about $443.9K. Pontifax Management 4 G.P. (2015) Ltd. is the 10%+ Owner of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $166.1K.
Signature
Pontifax Management 4 G.P. (2015) Ltd., By: /s/ Tomer Kariv, Chief Executive Officer
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Pontifax Management 4 G.P. (2015) Ltd. and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Pontifax Management 4 G.P. (2015) Ltd. has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $610,056.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Eloxx Pharmaceuticals, Inc. ($443,946).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Pontifax Management 4 G.P. (2015) Ltd.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELOX Eloxx Pharmaceuticals, Inc. 10%+ Owner $443,946 13 May 2021
KROS Keros Therapeutics, Inc. 10%+ Owner $166,110 -$84,975,125 -100% 15 Oct 2025
LBRX LB PHARMACEUTICALS INC 10%+ Owner 12 Sep 2025

Insider Transactions Reported by Pontifax Management 4 G.P. (2015) Ltd.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored